Research
Novartis study CKJX839D12302
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovascular events in high-risk primary prevention patients (VICTORION-1 PREVENT)
This study started enrolling in Autumn 2023 and has now enrolled 14,000 participants in over 45 countries
Nova 301 Trial
Join the Nova 301 Trial to find out if we can protect people 60 years of age or older against norovirus stomach bug symptoms
Enrolling Adults 60+: Help to see if we can protect people against symptoms caused by the norovirus stomach bug with an investigational mRNA vaccine
Fluent 1010
A clinical trial for an investigational mRNA seasonal flu vaccine
Seasonal flu can cause serious illness, especially for older people
In winter, seasonal flu can cause thousands of people in the UK to receive hospital treatment every day
The Fluent Trial is looking to recruit more than 56,000 people across Europe, North America and Asia to help research into an investigational mRNA jab against seasonal flu
Study of a vaccine for the prevention of Respiratory Syncytial Virus
GSK RSV - 012
Study of a vaccine for the prevention of Respiratory Syncytial Virus (RSV) infection and revaccination 222090 (RSV OA=ADJ-012)
Efficacy of AReSVi Vaccine in the Prevention of Respiratory Synctital Virus Types A and B
RSV is a common contagious virus affecting the lungs and breathing passages. It is one of the major remaining infectious diseases for which there is currently no vaccine or specific treatment.
LightHouse
The purpose of this study was to collect blood samples and medical information to help develop and evaluate a blood test that can screen for many cancers, including but not limited to lung, colorectal, ovarian, pancreatic, liver, bladder, stomach and oesophageal cancer from a single blood sample collection.
